Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24

Preprints.org(2023)10.20944/preprints202304.0389.v1Source: DataRank Database

Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24 is a research paper published in Preprints.org (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: greenTopics (33)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Bersabeh Tigabu,Rodrigo Pereira dos Santos ORCID,Philipp A. Ilinykh,Natalia P. Kuzmina ORCID,Olivia Vogel

Live enrichment

PubMed:21097893 OpenAlex:https://openalex.org/W4366256878

National Institutes of Health

Grant: 7U19AI109664-04

Therapeutics Targeting Filoviral interferon-antagonist and replication functions

National Institutes of Health

Grant: 5P01AI120943-03

Structural and Functional Characterization of the Ebola Virus Replication Complex

National Institutes of Health

Grant: 5R01AI148663-05

Intersection Between Viral Translation and Innate Immunity in the Context of Filovirus Infection

National Institutes of Health

Grant: 5R01AI123926-02

Multi-platform High Throughput Screens for Filoviral Replication Inhibitors

National Institutes of Health

Grant: 5R01AI161374-02

Development and characterization of engineered therapeutic antibodies against SARS-CoV-2

National Institutes of Health

Grant: 3R01AI143292-05S1

Novel VP30-host Interactions that Negatively Regulate Ebola Virus Infection

greenLicense: cc-by

repositoryhttps://www.preprints.org/manuscript/202304.0389/v1/download

repositoryhttps://doi.org/10.20944/preprints202304.0389.v1

https://doi.org/10.3390/v15051075

https://pubmed.ncbi.nlm.nih.gov/37243162

Fields of Study

Viral Infections and Outbreaks Researchinterferon and immune responsesViral Infections and Vectors0301 basic medicine03 medical and health sciences

Keywords

KaryopherinEbolavirusBiologyVirologyInterferonEbola virusNuclear transportGeneticsVirusGeneCell nucleusalpha Karyopherins570Biology and Life SciencesInterferon-betaHemorrhagic Fever, EbolaMicrobiologyQR1-502ArticleViral ProteinsSTAT1EbolaMedicine and Health SciencesHemorrhagic FeverHumansInterferonsVP24immune evasion

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Life in Land